James G. Marken - Aug 23, 2023 Form 4 Insider Report for ANI PHARMACEUTICALS INC (ANIP)

Role
SVP OPS & PROD DEV
Signature
/s/ James G. Marken, by attorney-in-fact Meredith W. Cook
Stock symbol
ANIP
Transactions as of
Aug 23, 2023
Transactions value $
-$247,716
Form type
4
Date filed
8/25/2023, 04:17 PM
Previous filing
Apr 12, 2023
Next filing
Feb 16, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANIP Common Stock Options Exercise $152K +3.75K +2.85% $40.59 135K Aug 23, 2023 Direct
transaction ANIP Common Stock Options Exercise $55K +1.67K +1.23% $33.00 137K Aug 23, 2023 Direct
transaction ANIP Common Stock Sale -$248K -3.93K -2.87% $63.00 133K Aug 23, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANIP Stock Option (right to buy) Options Exercise -$152K -3.75K -100% $40.59 0 Aug 23, 2023 Common Stock 3.75K $40.59 Direct F1
transaction ANIP Stock Option (right to buy) Options Exercise -$55K -1.67K -100% $33.00 0 Aug 23, 2023 Common Stock 1.67K $33.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the total options vested on each of April 7, 2017, April 7, 2018, April 7, 2019, and April 7, 2020.
F2 25% of the total options vested on each of April 1, 2015, April 1, 2016, April 1, 2017, and April 1, 2018.